Merck (MRK) Dividends payables (2009 - 2026)
Merck (MRK) reported Dividends payables of $2.1 billion for Q1 2026, up 3.18% year-over-year from $2.1 billion in Q1 2025, and little changed on a QoQ basis from $2.1 billion in Q4 2025.
Merck (MRK) has 18 years of Dividends payables data on file, last reported at $2.1 billion in Q1 2026.
- Quarterly Dividends payables rose 3.18% year-over-year to $2.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 billion (up 3.18% YoY) and the FY2025 annual result came in at $2.1 billion, up 2.69% from the prior year.
- Dividends payables was little changed at $2.1 billion in Q1 2026 per MRK's latest filing, from $2.1 billion in the prior quarter.
- Across five years, Dividends payables topped out at $2.1 billion in Q1 2026 and bottomed at $1.8 billion in Q2 2022.
- The 5-year median for Dividends payables is $2.0 billion (2024), against an average of $2.0 billion.
- The widest annual swing landed in 2023, when Dividends payables rose 7.68%; it then climbed 2.69% in 2025.
- Tracing MRK's Dividends payables over 5 years: stood at $1.9 billion in 2022, then climbed by 5.36% to $2.0 billion in 2023, then advanced by 4.99% to $2.1 billion in 2024, then advanced by 2.69% to $2.1 billion in 2025, then grew by 0.14% to $2.1 billion in 2026.
- Per Business Quant, the three latest MRK Dividends payables figures stand at $2.1 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.0 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | - |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 2.14 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | - |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | - |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.14 Bn |
| Dec 31, 2025 | 2.14 Bn |
| Sep 30, 2025 | 2.04 Bn |
| Jun 30, 2025 | 2.05 Bn |
| Mar 31, 2025 | 2.08 Bn |
| Dec 31, 2024 | 2.08 Bn |
| Sep 30, 2024 | 1.98 Bn |
| Jun 30, 2024 | 1.98 Bn |
| Mar 31, 2024 | 2.01 Bn |
| Dec 31, 2023 | 1.99 Bn |
| Sep 30, 2023 | 1.88 Bn |
| Jun 30, 2023 | 1.88 Bn |
| Mar 31, 2023 | 1.91 Bn |
| Dec 31, 2022 | 1.88 Bn |
| Sep 30, 2022 | 1.77 Bn |
| Jun 30, 2022 | 1.77 Bn |
| Mar 31, 2022 | 1.77 Bn |
| Dec 31, 2021 | 1.77 Bn |
| Sep 30, 2021 | 1.66 Bn |
| Jun 30, 2021 | 1.66 Bn |
| Mar 31, 2021 | 1.68 Bn |
| Dec 31, 2020 | 1.67 Bn |
| Sep 30, 2020 | 1.57 Bn |
| Jun 30, 2020 | 1.56 Bn |
| Mar 31, 2020 | 1.59 Bn |
| Dec 31, 2019 | 1.59 Bn |
| Sep 30, 2019 | 1.43 Bn |
| Jun 30, 2019 | 1.44 Bn |
| Mar 31, 2019 | 1.46 Bn |
| Dec 31, 2018 | 1.46 Bn |
| Sep 30, 2018 | 1.30 Bn |
| Jun 30, 2018 | 1.31 Bn |
| Mar 31, 2018 | 1.32 Bn |
| Dec 31, 2017 | 1.32 Bn |
| Sep 30, 2017 | 1.30 Bn |
| Jun 30, 2017 | 1.30 Bn |
| Mar 31, 2017 | 1.31 Bn |
| Dec 31, 2016 | 1.32 Bn |
| Sep 30, 2016 | 1.29 Bn |
| Jun 30, 2016 | 1.29 Bn |
| Mar 31, 2016 | 1.31 Bn |
| Dec 31, 2015 | 1.31 Bn |
| Sep 30, 2015 | 1.29 Bn |
| Jun 30, 2015 | 1.30 Bn |
| Mar 31, 2015 | 1.31 Bn |
| Dec 31, 2014 | 1.31 Bn |
| Sep 30, 2014 | 1.29 Bn |
| Jun 30, 2014 | 1.30 Bn |
| Mar 31, 2014 | 1.33 Bn |
| Dec 31, 2013 | 1.32 Bn |
| Sep 30, 2013 | 1.29 Bn |
| Jun 30, 2013 | 1.29 Bn |
| Dec 31, 2012 | 1.34 Bn |
| Jun 30, 2012 | 1.31 Bn |
| Mar 31, 2012 | 1.28 Bn |
| Dec 31, 2011 | 1.28 Bn |
| Sep 30, 2011 | 1.17 Bn |
| Jun 30, 2011 | 1.18 Bn |
| Mar 31, 2011 | 1.18 Bn |
| Dec 31, 2010 | 1.18 Bn |
| Sep 30, 2010 | 1.18 Bn |
| Jun 30, 2010 | 1.18 Bn |
| Mar 31, 2010 | 1.19 Bn |
| Dec 31, 2009 | 1.19 Bn |